MarketCap
Facebook
X
TelegramFluidigm Corporation DSO Ratio 2011-2025 | FLDM
Annual DSO Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 67.2 | 59.1 | 53.8 | 53.9 | 51.1 | 81 | 70.2 | 54.1 | 90 | 78.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90 | 51.1 | 65.9 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 20.74 | -3.8 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
101 | $ 0.23 | -1.7 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 39.74 | 0.89 % | $ 1.1 B | USA |
 |
Danaher Corporation
DHR
|
57 | $ 231.48 | 0.49 % | $ 169 B | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.52 | -0.09 % | $ 1.93 M | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 10.27 | 2.29 % | $ 291 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.58 | 0.01 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
85 | $ 67.69 | 0.18 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 26.79 | 0.26 % | $ 810 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.4 | -0.41 % | $ 1.04 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.18 | -0.62 % | $ 101 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 227.34 | 0.19 % | $ 41.2 B | USA |
 |
Guardant Health
GH
|
49.2 | $ 103.21 | 0.22 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
51.3 | $ 6.47 | -0.15 % | $ 586 M | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 4.94 | -1.0 % | $ 2.65 M | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 7.18 | 0.7 % | $ 1.56 B | USA |
 |
Illumina
ILMN
|
61.3 | $ 135.95 | 0.74 % | $ 21.6 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 204.53 | 0.48 % | $ 10.5 B | USA |
 |
National Research Corporation
NRC
|
33 | $ 18.68 | 0.11 % | $ 458 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 175.71 | -0.14 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 6.82 | - | $ 884 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 254.01 | 0.02 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 184.07 | 0.68 % | $ 15.2 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
43.6 | $ 688.92 | 0.06 % | $ 56.8 B | USA |
 |
Lantheus Holdings
LNTH
|
72 | $ 66.94 | 0.34 % | $ 4.63 B | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 419.95 | -0.03 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
63.8 | $ 138.67 | 0.2 % | $ 42.2 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.75 | 1.85 % | $ 6.32 M | USA |
 |
Bioventus
BVS
|
92.3 | $ 7.42 | -0.54 % | $ 465 M | USA |
 |
NeoGenomics
NEO
|
77.8 | $ 12.38 | 0.77 % | $ 1.57 B | USA |